Get the Stockscreener App
2.87
1.03%
-0.03
Pre-market:
2.87
Ispecimen Inc stock is traded at $2.87, with a volume of 45,100.
It is down -1.03% in the last 24 hours and down -25.65% over the past month.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
See More
Previous Close:
$2.90
Open:
$2.9
24h Volume:
45,100
Relative Volume:
0.10
Market Cap:
$2.76M
Revenue:
$10.39M
Net Income/Loss:
$-9.52M
P/E Ratio:
-0.1501
EPS:
-19.12
Net Cash Flow:
$-6.02M
1W Performance:
+3.61%
1M Performance:
-25.65%
6M Performance:
-47.05%
1Y Performance:
-74.82%
1-Day Range:
$2.81
$2.92
1-Week Range:
$2.7073
$3.13
52-Week Range:
$2.6216
$12.20
Ispecimen Inc Stock (ISPC) Company Profile
Name
Ispecimen Inc
Sector
Industry
Phone
781-301-6700
Address
8 CABOT ROAD, WOBURN
Compare ISPC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
2.87 | 2.76M | 10.39M | -9.52M | -6.02M | -19.12 |
|
TMO
Thermo Fisher Scientific Inc
|
544.93 | 208.44B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
238.09 | 171.97B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
137.00 | 39.13B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
204.32 | 37.08B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
432.36 | 35.40B | 3.84B | 866.24M | 792.60M | 10.37 |
Ispecimen Inc Stock (ISPC) Latest News
iSpecimen Inc. (NASDAQ:ISPC) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough - Simply Wall St
ISpecimen Inc. Appoints Yuying Liang as Chief Financial Officer - Marketscreener.com
ISpecimen Will Serve as a Preferred Provider of Cancer Biospecimens - Marketscreener.com
iSpecimen stock hits 52-week low at $2.75 amid market challenges - Investing.com
iSpecimen Strengthens Leadership and Expands Cancer Research Focus - TipRanks
iSpecimen expands cancer biospecimen services for research - Investing.com
iSpecimen Unveils Major Cancer Biospecimen Initiative, Partners with Leading Genomics Lab for 2025 Growth - StockTitan
Amazon.com Inc (AMZN-Q) QuotePress Release - The Globe and Mail
ISpecimen Inc. Appoints Robert Bradley Lim as Chief Executive Officer - Marketscreener.com
ISpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers - Marketscreener.com
Cal-Maine Foods IN (CALM-Q) QuotePress Release - The Globe and Mail
iSpecimen appoints Robert Lim as CEO - MSN
Pre-market Movers: LOOP, RPTX, CADL, INO, ISPC… - RTTNews
iSpecimen's Next Day Quote Program Drives 60% of Purchase Orders, Revolutionizing Biospecimen Sales - StockTitan
iSpecimen Appoints Robert Lim as New CEO - TipRanks
iSpecimen Appoints Robert Lim as CEO and Director - Newsfile
ISpecimen : Appoints Robert Lim as CEO and Director Form 8 K - Marketscreener.com
iSpecimen stock hits 52-week low at $3.4 amid market challenges By Investing.com - Investing.com South Africa
iSpecimen stock hits 52-week low at $3.4 amid market challenges - Investing.com
This Micro-Cap Stock Deserves a Second Look - RagingBull
ISpecimen Inc. Earns Investor Attention After Launching Milestone Cancer Biospecimen Offering - Marketscreener.com
Bernstein: 'Welcome to the crypto bull marketBuy everything you can' - Investing.com
iSpecimen Inc. Reports Earnings Amid Financial Challenges - TipRanks
iSpecimen Inc. Earns Investor Attention After Launching Milestone Cancer Biospecimen Offering - The Globe and Mail
iSpecimen Inc. Stock Surges After Announcing Expanded Cancer Biospecimen Offerings - The Globe and Mail
E.L.F. Beauty Inc (ELF-N) QuotePress Release - The Globe and Mail
ISpecimen Inc. Stock Surges After Announcing Expanded Cancer Biospecimen Offerings - Marketscreener.com
iSpecimen Inc. Stocks 48% Premarket Surge On Thursday Ignited A Regular Session Rally - The Globe and Mail
iSpecimen Emerges as Key Player in $13.5B Biospecimen Market, Shows 13.3% Growth Potential | ISPC Stock News - StockTitan
ISpecimen Inc. Stocks 48% Premarket Surge On Thursday Ignited A Regular Session Rally - Barchart
iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually - The Manila Times
iSpecimen Expands Cancer Sample Database, Projects $10M Annual Orders & 20% Growth | ISPC Stock News - StockTitan
iSpecimen Reports Third Quarter 2024 Results - The Manila Times
iSpecimen Q3 Revenue Dips Despite Cost-Cutting Push; Net Loss Narrows 32% | ISPC Stock News - StockTitan
Coinbase Global Inc Cl A (COIN-Q) QuotePress Release - The Globe and Mail
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - The Manila Times
iSpecimen Announces Public Offering to Support Growth - TipRanks
ISpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - Marketscreener.com
iSpecimen stock hits 52-week low at $3.41 amid market challenges By Investing.com - Investing.com South Africa
iSpecimen stock hits 52-week low at $3.41 amid market challenges - Investing.com
iSpecimen announces pricing of $5M public offering - TipRanks
iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - ForexTV.com
ISPCiSpecimen Inc. Latest Stock News & Market Updates - StockTitan
iSpecimen sets $5 million public stock offering at $3 per share - Investing.com
TSX Global Base Metals EW Index (TXBE) QuotePress Release - The Globe and Mail
Short Interest in iSpecimen Inc. (NASDAQ:ISPC) Decreases By 86.9% - MarketBeat
Whirlpool Corp (WHR-N) QuotePress Release - The Globe and Mail
Canacol Energy Ltd (CNNEF) QuotePress Release - The Globe and Mail
Specimen Validity Testing Market Report 2024Specimen - openPR
Ispecimen Inc Stock (ISPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):